(a) Any "invitation to contract," as defined in §21.102 of this title (relating to Scope), used in the marketing, solicitation, or sale of a life insurance contract containing an acceleration-of-life-insurance provision must clearly and concisely disclose the following:
  (1) the illness, condition, care, or confinement necessary to trigger eligibility for any acceleration-of-life-insurance benefit;
  (2) the effect that an acceleration-of-life-insurance benefit provision will have on the death benefit and other values available under the life insurance contract; and
  (3) the tax-related disclosures contained in either subsection (a) or (b) of §4.1116 of this title (relating to Disclosures Related to Tax Qualification of Benefits and Benefits' Effect on Public Assistance), as appropriate, and the disclosure contained in subsection (c) of §4.1116, or disclosures substantially similar to these disclosures.
(b) No insurer or agent, in marketing a life insurance contract that provides acceleration-of-life-insurance benefits, may mention, illustrate, or refer to the contract as an alternative or substitute for catastrophic major medical health insurance.

Source Note: The provisions of this §4.1113 adopted to be effective March 1, 1998, 23 TexReg 1585; transferred effective April 16, 1999, 24 TexReg 3092; amended to be effective June 23, 2008, 33 TexReg 4884; transferred effective September 1, 2023, as published in the July 28, 2023, issue of the Texas Register, 48 TexReg 4127; amended to be effective January 24, 2024, 49 TexReg 250